BioVentures — 2015 Investments

1 investments dated 2015 · listed companies and verified rows first · show all

Profusaprofusa.comin 𝕏NASDAQ: PFSAJun 2015SEC filingmedium confidence

Profusa develops injectable hydrogel biosensors and AI-driven health platforms that enable real-time measurement of body chemistry from within tissue.

AI & Machine LearningDigital HealthHealthtechMedical DevicesSan Francisco, US

Bill Fawcett(Co-founder)Ben Healy(CEO)Natalie Wisniewski(Executive Officer, Director)Qianye Karen Liu(Director)Ben Hwang(Executive Officer, Director)Thomas Gutshall(Director)

Board seatQianye Karen Liu· per SEC Form D · $17M raise · filed Jul 2015

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.